FREEHOLD, N.J., April 09, 2024 Chromocell Therapeutics Corporation , , a pioneer in the development of non-opioid pain treatment therapeutics, today announced that its Chief Executive Officer,.
Chromocell Therapeutics Co.'s (NYSE:CHRO) Quiet Period Set To Expire on March 27th theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Chromocell Therapeutics Announces Closing of Initial Public Offering for Gross Proceeds of $6.6 Million tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public Offering tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Form S-1/A Chromocell Therapeutics streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.